Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Long-term treatment of girls with ornithine transcarbamylase deficiency.

Maestri NE, Brusilow SW, Clissold DB, Bassett SS.

N Engl J Med. 1996 Sep 19;335(12):855-9.

2.

Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients.

Burlina AB, Ogier H, Korall H, Trefz FK.

Mol Genet Metab. 2001 Apr;72(4):351-5.

PMID:
11286510
3.

Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.

Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A.

N Engl J Med. 2007 May 31;356(22):2282-92.

4.

Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse.

Batshaw ML, Hyman SL, Coyle JT, Robinson MB, Qureshi IA, Mellits ED, Quaskey S.

Pediatr Res. 1988 Apr;23(4):368-74.

PMID:
3374991
5.

Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.

Scaglia F, Carter S, O'Brien WE, Lee B.

Mol Genet Metab. 2004 Apr;81 Suppl 1:S79-85.

PMID:
15050979
6.

Amino acid acylation: a mechanism of nitrogen excretion in inborn errors of urea synthesis.

Brusilow S, Tinker J, Batshaw ML.

Science. 1980 Feb 8;207(4431):659-61.

PMID:
6243418
7.

Chronic benzoate therapy in a boy with partial ornithine transcarbamylase deficiency.

Letarte J, Qureshi IA, Ouellet R, Godard M.

J Pediatr. 1985 May;106(5):794-7. No abstract available.

PMID:
3998920
8.

Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.

Brusilow SW, Danney M, Waber LJ, Batshaw M, Burton B, Levitsky L, Roth K, McKeethren C, Ward J.

N Engl J Med. 1984 Jun 21;310(25):1630-4.

PMID:
6427608
9.

Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency.

Takeda E, Kuroda Y, Toshima K, Watanabe T, Naito E, Miyao M.

Clin Pediatr (Phila). 1983 Mar;22(3):206-8.

PMID:
6825366
10.

The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency.

Busuttil AA, Goss JA, Seu P, Dulkanchainun TS, Yanni GS, McDiarmid SV, Busuttil RW.

Liver Transpl Surg. 1998 Sep;4(5):350-4. Review.

11.

Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy.

Pridmore CL, Clarke JT, Blaser S.

J Child Neurol. 1995 Sep;10(5):369-74.

PMID:
7499756
12.

Prospective management of a child with neonatal citrullinemia.

Melnyk AR, Matalon R, Henry BW, Zeller WP, Lange C.

J Pediatr. 1993 Jan;122(1):96-8.

PMID:
8419623
13.

Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.

Batshaw ML, Msall M, Beaudet AL, Trojak J.

J Pediatr. 1986 Feb;108(2):236-41.

PMID:
3944708
14.

Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.

Batshaw ML, Brusilow S, Waber L, Blom W, Brubakk AM, Burton BK, Cann HM, Kerr D, Mamunes P, Matalon R, Myerberg D, Schafer IA.

N Engl J Med. 1982 Jun 10;306(23):1387-92.

PMID:
7078580
15.

Prospective treatment of urea cycle disorders.

Maestri NE, Hauser ER, Bartholomew D, Brusilow SW.

J Pediatr. 1991 Dec;119(6):923-8.

PMID:
1720458
16.

Sodium benzoate and arginine: alternative pathway therapy in inborn errors of urea synthesis.

Batshaw ML.

Prog Clin Biol Res. 1983;127:69-83. No abstract available.

PMID:
6889404
17.

Severe ornithine transcarbamylase deficiency. Two and a half years' survival with normal development.

Guibaud P, Baxter P, Bourgeois J, Louis JJ, Bureau J.

Arch Dis Child. 1984 May;59(5):477-9.

18.

Unusual biochemical and clinical features in a girl with ornithine transcarbamylase deficiency.

Lacey DJ, Duffner PK, Cohen ME, Mosovich L.

Pediatr Neurol. 1986 Jan-Feb;2(1):51-3.

PMID:
3508674
19.

Successful treatment of severe carbamyl phosphate synthetase I deficiency.

Van de Bor M, Mooy P, van Zoeren D, Berger R, van Gelderen HH, Teijema HL.

Arch Dis Child. 1984 Dec;59(12):1183-5.

20.

Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate.

del Rosario M, Werlin SL, Lauer SJ.

J Clin Gastroenterol. 1997 Dec;25(4):682-4.

PMID:
9451687

Supplemental Content

Support Center